Sinclair Pharma, IS Pharma merge to form pan-European specialty pharma firm

Sinclair IS Pharma will be headquartered in UK with direct distribution operations in the UK, France, Germany, Italy, Spain and Ireland and its own manufacturing and product development capability.

Sinclair Pharma chairman Grahame Cook said the merger of Sinclair Pharma and IS Pharma will create in a single transaction an integrated pan-European specialty pharma company with greater critical mass, international reach and a more diversified product portfolio than was achievable in the short term in the two separate companies.

IS Pharma chairman John Gregory said the increased scale of the enlarged group will provide IS Pharma with a direct presence in the top five European markets as well as strengthening the product portfolio and providing in-house development capabilities to both companies.

The merger will be conditional on, amongst other things, the approval of the Sinclair Pharma Shareholders and the approval of the IS Pharma Shareholders.